News

Piper Sandler Updates Price Target for Hanover Bancorp Stock

Piper Sandler Updates Price Target for Hanover Bancorp Stock

Piper Sandler Updates Price Target for Hanover Bancorp

Piper Sandler has recently revised its price target for Hanover Bancorp, Inc. (NASDAQ: HNVR), increasing it to $22.00 from the previous $20.00. This adjustment comes while maintaining an Overweight rating on the stock, reflecting the firm’s strong confidence in the company’s growth potential.

Strong Earnings Report for Hanover Bancorp

The revision was propelled by Hanover Bancorp's recent earnings report for the third quarter of 2024, which showcased impressive figures that outstripped analyst expectations. During this period, the company disclosed earnings per share (EPS) of $0.48. Nevertheless, when factoring out one-time items, the core EPS was calculated at a remarkable $0.50.

Exceeding Analysts' Expectations

This core EPS of $0.50 surpassed Piper Sandler's own estimate by $0.09, hitting a positive variance of 21%. Additionally, it was $0.05 above the consensus estimate from other market analysts, signifying an 11% beat. Such performance underlines a strong operational capability within the company as it continues to exceed market expectations.

Key Financial Metrics and Performance

Hanover Bancorp's core results reveal a return on assets (ROA) of 64 basis points, alongside a return on tangible common equity (ROTCE) of 8.6%. These financial metrics indicate a sturdy performance for the quarter, and Piper Sandler acknowledged these results as a testament to the robustness of Hanover Bancorp's operational efficiency in the competitive banking landscape.

Future Outlook for Hanover Bancorp Stock

The analysts at Piper Sandler have signaled a positive sentiment towards the future of Hanover Bancorp's stock performance. They project that the shares are well-positioned for favorable movements in the market, particularly looking ahead to upcoming trading sessions. This outlook could instill confidence among investors considering an involvement with the stock.

Conclusion

The adjustments made by Piper Sandler, bolstered by solid earnings and key financial ratios, contribute to a comprehensive understanding of Hanover Bancorp’s potential. With the updated price target reflecting a promising trajectory, investors may find renewed interest in the company. The communicated strength of the financial performance and the Overweight rating set up an optimistic view for those monitoring Hanover Bancorp, Inc. (NASDAQ: HNVR).

Frequently Asked Questions

What is the new price target for Hanover Bancorp by Piper Sandler?

Piper Sandler has raised the price target for Hanover Bancorp to $22.00 from $20.00.

What earnings per share did Hanover Bancorp report?

Hanover Bancorp reported earnings per share of $0.48, with core EPS adjusted to $0.50.

How did Hanover Bancorp's earnings compare against estimates?

The earnings exceeded Piper Sandler's estimate by $0.09, achieving a 21% positive variance.

What key financial metrics were reported?

The company recorded a return on assets (ROA) of 64 basis points and a return on tangible common equity (ROTCE) of 8.6%.

What is the sentiment of Piper Sandler on Hanover Bancorp's market position?

Piper Sandler holds a positive outlook on Hanover Bancorp’s stock performance going forward, anticipating favorable movements in the market.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Elbit Systems Lands $200M APAC ISTAR Contracts

Updated Category News Views 100

Elbit Systems Secures Major Asia-Pacific Deal You know, it's not every day that a defense contractor like Elbit Systems (NASDAQ:ESLT) bags a $200 million deal in the Asia-Pacific region. A big move in a high-stakes game where technology, strategy, and geography collide. This isn't some random supply deal; this involves the cutting edge of defense tech—ISTAR and training...

Continue Reading
OncoHost's Research Links TKI Sensitivity to Biology

Updated Category News Views 149

Cracking the Code on TKI Sensitivity When it comes to medicine, sometimes the trickiest part is knowing which button to push—especially in the high-stakes world of metastatic renal cell carcinoma (mRCC). OncoHost just dropped a bombshell at the ESMO 2026 Congress about their new plasma proteomics model that lets us peer into what makes some patients click with Tyrosine...

Continue Reading
Golden Bear Faces Wage Violation Class Action Case

Updated Category News Views 22

Legal Battle Brewing in Merced Well, folks, looks like Golden Bear Physical Therapy Sports Injury Center, Inc. is in for a bumpy ride. The company is facing a whopper of a class action lawsuit, filed by the folks over at Blumenthal Nordrehaug Bhowmik De Blouw LLP, alleging violations of the California Labor Code. This legal skirmish is unfolding right there in the Merced...

Continue Reading
Post University Expands with New Tech and Health Degrees

Updated Category News Views 31

If you're looking to invest in an education with promising payoffs, you might look into what's cooking over at Post University. They've just dropped a bombshell of new programs sure to get some attention from tech heads and health nuts alike, and I can't help but think there's potential brewing here. New Academic Paths Emerge Post University isn't resting on its...

Continue Reading
Columbia Distributing Expands to Alaska: A Growth Move

Updated Category News Views 0

Alaska's Entry: Columbia's New Frontier When Columbia Distributing dives into a new territory, you know they're serious about growth. This latest move sees them planting their flag in Alaska, finally completing a strategic vision that's been brewing for a while. Four-State Strategy Comes to Fruition The transaction with Republic National Distributing Company (RNDC) is no...

Continue Reading
HONOR X9e Pro Unveils with Massive Battery Power

Updated Category News Views 123

Lighting Up the Sky: HONOR's Big Move Picture this: the Burj Khalifa in Dubai, world’s tallest building, flashing with the promise of a smartphone's monstrous battery. That’s what the fine folks at HONOR did, highlighting their X9e Pro and its mind-boggling 11,000mAh battery. Now, am I the only one who finds it more than a little audacious to leverage such a flashy...

Continue Reading
EQT Acquires Range Resources: Redefining Gas Markets

Updated Category News Views 204

A New Chapter in Natural Gas Who would have thought? EQT Corporation, that sturdy old veteran in the natural gas game, finally made its move and snatched up Range Resources, sprinting right out of left field. This merger isn't just about two companies shaking hands; it's about rewriting the entire narrative of America's natural gas landscape. With this acquisition, EQT's...

Continue Reading
Bank of America Faces Class-Action Suit in Court

Updated Category News Views 54

Mixed Bag for Bank of America Investors If you thought you could just park your cash in big banks and slumber through the financial year, think again. Bank of America (NYSE: BAC) has found itself in hot water with a securities fraud class-action suit looming over what some are calling a pretty nasty oversight in compliance. A 4.76% stock drop was a bitter sip for those...

Continue Reading
China's 15th Plan: Key Moves in the Capital Markets

Updated Category News Views 196

Riding the Waves of Reform in China The winds of change are blowing through China's capital markets, and Guosen Securities is putting a stake in the ground with bold priorities for the 15th Five-Year Plan. As far as I'm concerned, the headlines here are thick with implications for anyone eyeing a piece of China's economic pie from 2026–2030. The Pillars of Stability and...

Continue Reading
Bank of America Faces Legal Battle Over Compliance Failures

Updated Category News Views 75

Another Day, Another Lawsuit Just when you thought the financial waters were calm, there's a storm brewing for Bank of America Corp. (NYSE: BAC). They've been slapped with a securities class action lawsuit that screams all kinds of regulatory and compliance failures. You’d think with all that cash flow, BAC could afford to run a tight ship. But apparently, they decided...

Continue Reading
News Section End -->

Top 5 Most Recently Viewed Articles

Exciting Backyard Trends for 2025: TurfMutt Foundation Insights

Updated Category News Views 208

Backyarding Trends to Watch in 2025 The TurfMutt Foundation has identified a notable increase in backyarding trends for 2025, reflecting the growing appreciation for outdoor living. This movement encourages people to transition everyday activities such as dining, relaxing, and socializing to the great outdoors, utilizing spaces like yards, parks, and community gardens. As...

Continue Reading
Ajax Health Teams Up with KKR to Combat Heart Failure

Updated Category News Views 163

Ajax Health and KKR Collaborate on Heart Failure Solutions Ajax Health, supported by KKR, has formed a new platform called FlowMod, focusing on innovative treatment options for heart failure. This condition is a pressing health issue globally, significantly affecting the heart's ability to pump blood effectively. Today, approximately 64 million individuals suffer from...

Continue Reading
Innovative Consulting by STRATA Skin Sciences Boosts Clinic Success

Updated Category News Views 106

Transforming Partner Clinic Operations with E360 STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a leader in medical technology focused on dermatologic treatments, is making waves with its innovative Elevate 360 (E360) consulting services. This program is helping partner clinics tap into the full potential of their operations, particularly when utilizing STRATA's acclaimed...

Continue Reading
Sandoz Introduces Pyzchiva®: A New Solution for Immune Disorders

Updated Category News Views 165

Pyzchiva® Launches: A Milestone for Immunology Treatment In a significant development for patients suffering from chronic inflammatory diseases, Sandoz has announced the launch of Pyzchiva® (ustekinumab-ttwe) in the United States. This launch not only expands Sandoz's product lineup but also reflects the company's commitment to providing accessible treatment options for...

Continue Reading
Investors May Lead Class Action Against Hims & Hers Health

Updated Category News Views 175

Class Action Opportunity for Investors in Hims & Hers Health The renowned law firm Robbins Geller Rudman & Dowd LLP has stepped forward to announce an opportunity for investors of Hims & Hers Health, Inc. (NYSE: HIMS) facing significant financial losses. This is a remarkable moment for those who acquired Hims & Hers securities between specific periods to take action and...

Continue Reading